GleamWall
中文EN

AXGN Axogen, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 805928 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY24.3%
TTM net income YoY-1,422.3%
TTM EPS YoY-1,160.0%
Revenue 3-yr CAGR20.6%
Net income 3-yr CAGR—

Margins

Gross margin74.2%
Operating margin-5.2%
Net margin-12.0%
FCF margin8.3%
EBITDA margin-2.8%

Returns

ROE-10.3%
ROA-8.3%
ROIC (approx.)-7.1%
Asset turnover0.70x

Leverage & solvency

Liabilities / assets9.9%
Debt / equity0.00x
Current ratio12.02x
Interest coverage-5.72x

Cash quality & payout

Operating cash flow / net income-0.89x
Accruals ratio-15.7%
Payout ratio—
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$75.83M$69.73M$61.46M$59.90M$60.08M$56.66M$48.56M$49.41M
Cost of revenue$19.10M$19.06M$15.27M$15.49M$14.09M$14.64M$13.63M$11.83M
Gross profit$56.73M$50.67M$46.19M$44.41M$45.99M$42.02M$34.93M$37.58M
R&D expense$8.95M$8.59M$7.52M$12.38M$7.57M$6.85M$6.09M$6.70M
SG&A expense$16.46M$13.41M$12.87M$14.59M$10.84M$9.69M$9.46M$8.83M
Operating income$955,000-$2.16M-$2.83M-$9.77M$1.91M$1.67M-$1.66M$2.02M
Interest expense$1,000$1,000$694,000$1.72M$1.76M$1.98M$2.25M$1.80M
Income tax$0$0$0$0$0$0$0$0
Net income$2.33M-$1.52M-$19.58M-$13.16M$708,000$579,000-$3.83M$450,000
EBITDA$2.53M-$549,000-$1.23M-$8.14M$3.55M$3.33M$67,000$3.65M
EPS (basic)0.04-0.03-0.38—0.020.01-0.08—
EPS (diluted)0.04-0.03-0.38—0.010.01-0.08—
Weighted avg. shares (diluted)61.53M53.34M51.59M—49.09M47.98M45.20M—
Balance sheet
Cash & equivalents$328.89M$94.57M$82.65M$35.55M$27.90M$26.04M$24.10M$33.55M
Short-term investments$19.18M$16.84M$18.95M$5.98M$11.89M$9.89M$3.97M$5.93M
Receivables$34.01M$34.13M$28.31M$26.17M$30.77M$28.03M$26.30M$24.11M
Inventory$49.06M$47.31M$46.07M$42.37M$40.58M$36.77M$35.50M$33.18M
Current assets$438.09M$200.38M$184.71M$120.42M$114.46M$103.42M$93.07M$99.22M
PP&E, net$81.95M$82.34M$83.04M$81.78M$82.37M$82.39M$83.31M$84.67M
Intangibles$7.91M$7.57M$7.27M$6.75M$6.43M$6.12M$5.88M$5.58M
Total assets$550.34M$304.86M$289.49M$221.69M$216.40M$205.45M$196.16M$203.73M
Current liabilities$36.46M$30.37M$26.01M$23.56M$28.01M$24.98M$21.75M$30.61M
Long-term debt$0$0$0$48.39M$48.16M$47.94M$47.72M$47.50M
Total debt$0$0$0$48.39M$48.16M$47.94M$47.72M$47.50M
Total liabilities$54.24M$48.61M$44.68M$92.84M$95.59M$93.18M$90.80M$99.82M
Shareholders' equity$496.10M$256.26M$244.81M$128.85M$120.81M$112.28M$105.36M$103.91M
Net debt-$328.89M-$94.57M-$82.65M$12.84M$20.26M$21.90M$23.62M$13.94M
Shares outstanding59.72M53.66M53.15M47.20M46.12M45.77M45.51M44.15M
Cash flow statement
Operating cash flow$16.54M$7.22M$1.56M$3.04M$3.22M$7.73M-$13.18M$8.73M
Capital expenditure$1.39M$893,000$2.79M$1.25M$1.52M$722,000$256,000$670,000
Free cash flow$15.14M$6.33M-$1.22M$1.79M$1.70M$7.01M-$13.44M$8.06M
Investing cash flow-$10.93M$500,000-$15.96M$4.04M-$3.75M-$6.95M$1.34M-$813,000
Financing cash flow$228.71M$4.20M$59.51M$4.57M$2.39M$1.16M$2.38M$970,000
Depreciation & amortization$1.58M$1.61M$1.60M$1.63M$1.64M$1.66M$1.73M$1.64M
Stock-based compensation$8.79M$8.77M$6.84M$16.61M$5.42M$5.17M$2.91M$3.08M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.